U.S. lawmaker seeks congressional hearing on ‘superbug’ outbreak

Published 02/23/2015, 05:15 PM
© Reuters. People walk past the entrance to the Ronald Reagan UCLA Medical Center in Los Angeles, California

By Dan Whitcomb

LOS ANGELES (Reuters) - A U.S. lawmaker on Monday called on the Congress to investigate the medical scopes blamed for an outbreak of a bacterial "superbug" at a University of California, Los Angeles hospital that has infected seven patients.

Representative Ted Lieu, a Democrat from California, said in a letter asking for a congressional oversight committee hearing that the outbreak of the drug-resistant Enterobacteriaceae, or CRE, bacteria posed "both health and national security" risks.

"If unmitigated, the human and societal costs of CRE outbreaks will continue to rise," Lieu wrote in the letter.

"A superbug infection can kill not only the patient who was exposed to a tainted duodenoscope but also family members, friends and hospital staff who interacted with the patient," he said.

Officials say the duodenoscopes, which are inserted down a patient's throat during gastrointestinal procedures, spread the antibiotic-resistant bacteria to seven patients at the UCLA Ronald Reagan Medical Center, contributing to two deaths. The other five are under treatment.

An additional 179 people who had endoscopies at the large teaching hospital may have been exposed to the potentially fatal pathogens, according to UCLA.

On Friday, a U.S. Centers for Disease Control and Prevention scientist said the agency was close to unveiling a detailed procedure designed to prevent the scopes from spreading the superbug.

Called a "surveillance culture," the procedure involves swabbing the device after it has been disinfected and then allowing any microbes to grow into detectable colonies, much as doctors take throat swabs to determine if a patient has a strep infection.

The UCLA medical center has said it had been sterilizing the duodenoscopes implicated in the infection according to manufacturer standards. It has said it now uses a more rigorous process that exceeds national standards.

Hospitals across the United States have reported exposures from the same type of medical equipment in recent years. The U.S. Food and Drug Administration has said it was working with other government agencies and scope manufacturers to minimize risks to patients.

© Reuters. People walk past the entrance to the Ronald Reagan UCLA Medical Center in Los Angeles, California

(Story has been refiled to correct typographical error in headline)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.